For a complete overview of Kowa Company, Ltd.'s drug candidates currently in Phase I or later clinical development, please click on the following link:
http://www.kowa.co.jp/eng/g/rd/pipeline.htm
|
Candidate |
Phase |
Indication |
Target NDA |
|
PRO-513 |
NDA Submitted |
Migraine |
2008 |
|
NK-104 (Pitavastatin) |
NDA Submitted |
Hyperlipidemia |
2008 |
